63552-722Level 3
FLUZONE HIGH DOSE NORTHERN HEMISPHERE (influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/croatia/10136/rv/2023 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated))
**Product type:** Vaccine
**Active ingredient:** INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)
**Strength:** 60; 60; 60 ug/.5mL; ug/.5mL; ug/.5mL
**Dosage form:** Injection, Suspension
**Route:** Intramuscular
**Labeler:** Patheon Manufacturing Services LLC
**Marketing category:** BLA (BLA103914)
GET
/api/v1/systems/ndc_fda/nodes/63552-722Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.